Survival and prognostic factors in resected N2 non-small cell lung cancer: A study of 140 cases

[1]  E. Wouters,et al.  Hormonal treatment in advanced non-small cell lung cancer: fact or fiction? , 1996, The European respiratory journal.

[2]  N. Aaronson,et al.  Effects of medroxyprogesterone acetate on appetite, weight, and quality of life in advanced-stage non-hormone-sensitive cancer: a placebo-controlled multicenter study. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  I Yoshino,et al.  Prognostic factors obtained by a pathologic examination in completely resected non-small-cell lung cancer. An analysis in each pathologic stage. , 1995, The Journal of thoracic and cardiovascular surgery.

[4]  J. Régnard,et al.  Preoperative carcinoembryonic antigen level as a prognostic indicator in resected primary lung cancer. , 1994, The Annals of thoracic surgery.

[5]  C. Mountain.  Surgery for stage IIIa‐N2 non‐small cell lung cancer , 1994, Cancer.

[6]  R. V. van Klaveren,et al.  Prognosis of unsuspected but completely resectable N2 non-small cell lung cancer. , 1993, The Annals of thoracic surgery.

[7]  J. Roth,et al.  Prognostic significance of computed tomography in resected N2 lung cancer. , 1992, The Annals of thoracic surgery.

[8]  P. Goldstraw.  The practice of cardiothoracic surgeons in the perioperative staging of non-small cell lung cancer. , 1992, Thorax.

[9]  M. Oda,et al.  Aggressive surgical intervention in N2 non-small cell cancer of the lung. , 1991, The Annals of thoracic surgery.

[10]  K. Sugimachi,et al.  Surgical treatment of patients with nonsmall‐cell lung cancer and mediastinal lymph node involvement , 1990, Journal of surgical oncology.

[11]  R. Tsuchiya,et al.  The importance of surgery to non-small cell carcinoma of lung with mediastinal lymph node metastasis. , 1988, The Annals of thoracic surgery.

[12]  S. Piantadosi,et al.  Should subcarinal lymph nodes be routinely examined in patients with non-small cell lung cancer? , 1988 .

[13]  N. Martini,et al.  The role of surgery in N2 lung cancer. , 1987, The Surgical clinics of North America.

[14]  R. Ginsberg,et al.  Significance of metastatic disease in subaortic lymph nodes. , 1987, The Annals of thoracic surgery.

[15]  J. Deslauriers,et al.  Role of mediastinoscopy in pretreatment staging of patients with primary lung cancer. , 1985, The Annals of thoracic surgery.

[16]  T. Naruke,et al.  Prognostic Significance of Extranodal Cancer Invasion of Mediastinal Lymph Nodes in Lung Cancer , 1982 .

[17]  M. Kirsh,et al.  Mediastinal metastases in bronchogenic carcinoma: influence of postoperative irradiation, cell type, and location. , 1982, The Annals of thoracic surgery.

[18]  W. Lane,et al.  The value of carcinoembryonic antigen in patients with carcinoma of the lung , 1979, Cancer.

[19]  T. Naruke,et al.  Lymph node mapping and curability at various levels of metastasis in resected lung cancer. , 1978, The Journal of thoracic and cardiovascular surgery.

[20]  G. Liebler,et al.  Prognostic value of preoperative carcinoembryonic antigen (CEA) plasma levels in patients with bronchogenic carcinoma , 1978, Cancer.

[21]  G. Higgins,et al.  Prognostic factors in lung cancer. Surgical aspects. , 1969, The Annals of thoracic surgery.

[22]  A. Dujon,et al.  Factors determining survival in resected N2 lung cancer. , 1995, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[23]  P. Goldstraw,et al.  Surgical management of non-small-cell lung cancer with ipsilateral mediastinal node metastasis (N2 disease). , 1994, The Journal of thoracic and cardiovascular surgery.

[24]  D. Azoulay,et al.  Results of resection for bronchogenic carcinoma with mediastinal lymph node metastases in selected patients. , 1991, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[25]  N. Chakfé,et al.  CANCERS BRONCHIQUES NON ANAPLASIQUES, N2, OPERES EVALUATION MULTIFACTORIELLE DU PRONOSTIC , 1991 .

[26]  T. Shields.  The significance of ipsilateral mediastinal lymph node metastasis (N2 disease) in non-small cell carcinoma of the lung. A commentary. , 1990, The Journal of thoracic and cardiovascular surgery.

[27]  P. Pairolero,et al.  Treatment of "limited" stage III non-small cell carcinoma of the lung. , 1988, Cancer investigation.

[28]  G. Maggi.  Results of radical treatment of stage IIIa non-small-cell carcinoma of the lung. , 1988, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[29]  J. Cooper,et al.  Significance of positive superior mediastinal nodes identified at mediastinoscopy in patients with resectable cancer of the lung. , 1982, The Journal of thoracic and cardiovascular surgery.